Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-011690

President & CSO sold 17,634 shares at $16.48 ($290,642)

From the SEC's structured data for this filing

Trades in this filing

Shacham Sharon · President & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-19 Sale : show line 1 in the form −8,817 $16.48 $145,321 756,489 D
2020-02-19 Sale : show line 2 in the form −8,817 $16.48 $145,321 555,122 I
Open-market sales · 17,634 sh · avg $16.48 · $290,642
Loading xslF345X03/doc4.xml…